Doximity Goodwill and Intangible Assets 2020-2025 | DOCS

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Total Assets Cash on Hand Long Term Debt Total Liabilities

Doximity goodwill and intangible assets for 2025 were $0.091B, a 4.46% decline from 2024.
Doximity goodwill and intangible assets for 2024 were $0.095B, a 4.53% decline from 2023.
Doximity goodwill and intangible assets for 2023 were $0.1B, a 271.97% increase from 2022.

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Total Assets Cash on Hand Long Term Debt Total Liabilities

Doximity goodwill and intangible assets for 2025 were $0.091B, a 4.46% decline from 2024.
Doximity goodwill and intangible assets for 2024 were $0.095B, a 4.53% decline from 2023.
Doximity goodwill and intangible assets for 2023 were $0.1B, a 271.97% increase from 2022.

Related Stocks
Company Name	Market Cap
Veeva Systems (VEEV)	$46B
Hims & Hers Health (HIMS)	$14B
Tempus AI (TEM)	$9.5B
IRhythm Technologies (IRTC)	$5.3B
Inspire Medical Systems (INSP)	$3.7B
Hinge Health (HNGE)	$3.5B
Privia Health (PRVA)	$2.3B
10x Genomics (TXG)	$1.6B
Phreesia (PHR)	$1.6B
Azenta (AZTA)	$1.5B
Enovis (ENOV)	$1.5B
Schrodinger (SDGR)	$1.4B
Clover Health Investments (CLOV)	$1.4B
Omnicell (OMCL)	$1.4B
Evolent Health (EVH)	$1.2B
Claritev (CTEV)	$632M
Fulgent Genetics (FLGT)	$564M
Veradigm (MDRX)	$525M
Standard BioTools (LAB)	$494M
Talkspace (TALK)	$387M
Carlsmed (CARL)	$361M
Butterfly Network (BFLY)	$346M
TruBridge (TBRG)	$309M
Outset Medical (OM)	$267M
Nyxoah SA (NYXH)	$249M
Health Catalyst (HCAT)	$245M
SOPHiA GENETICS SA (SOPH)	$211M
Zepp Health (ZEPP)	$188M
CapsoVision (CV)	$181M
KORU Medical Systems (KRMD)	$161M